BridgeMD
New treatment option for Surgery
Official title Pediatric Pilonidal Sinus Surgical Treatment
ClinicalTrials.gov ID: NCT07369921
What this study is testing
- What it's testing
- The aim of study to evaluate four different treatment options for pilonidal sinus disease in a randomized controlled trial to find the most suitable treatment option.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18
You may be able to join if
- having sacrococcygeal pilonidal sinus disease
- written informed (family) consent were eligible for inclusion in this trial
You likely can't join if
- Being over 18 years old or under 12 years old
- recurrent sacrococcygeal pilonidal sinus disease
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Umraniye, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Umraniye, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.